Amodei Says AI Will Cure Cancer in a Decade. Doctors Are Skeptical

Anthropic CEO Dario Amodei predicted that cancer, Alzheimer’s, heart disease, and mental illness could become “relics of the past” in less than a decade, crediting AI’s potential to transform medicine. He made the claim in a 42-minute video promoting the company ahead of a planned IPO, where Anthropic is seeking investor support for a valuation reportedly near $1 trillion. The forecast drew sharp objections from doctors, researchers, and biotech figures, who argued that AI may help medical research but cannot plausibly eliminate such complex diseases on that timetable. Germany’s former health minister Karl Lauterbach called the timeline impossible; AI medical researcher Melinda Chu said Anthropic had not shown it could meaningfully advance these goals, while biotech executive Rami Elghandour criticized the prediction as an extreme IPO pitch.

The skepticism also reflects a contrast between Amodei’s earlier caution and his current optimism. He has often warned about AI’s dangers and previously acknowledged that promising AI as a way to cure cancer can sound clichéd or deceptive. Yet he has increasingly emphasized medicine’s potential benefits as a way to persuade AI skeptics. Anthropic has taken steps into drug development, including acquiring several biotech startups, beginning its own drug-discovery work, and opening a Bay Area laboratory for biological research. These initiatives show growing interest in applying AI to health, but the critics’ central point is that such activity does not substantiate promises to cure several major diseases within ten years.